Clinical Development

The Clinical Development team at Recordati Rare Diseases North America is responsible for planning, executing, and overseeing clinical trials to evaluate the safety and efficacy of new therapies for rare diseases. This team collaborates closely with medical affairs, regulatory agencies, and stakeholders in the rare disease community to ensure that innovative treatments are brought to market effectively and ethically. By leveraging expertise in various therapeutic areas, including oncology and endocrinology, the team strives to advance medical knowledge and enhance patient care.